Top

Published in:

01-05-2015 | Research Article

Association between the genetic variations within TBX21 gene promoter and the clinicopathological characteristics of esophageal squamous cell carcinoma in a high-risk Chinese population

Authors: Huihui Li, Hongchao Zhen, Lei Han, Bo Yan, Jing Yu, Shengtao Zhu, Bangwei Cao

Published in: Tumor Biology | Issue 5/2015

Abstract

The correlation between TBX21 gene (T-box transcription factor protein 21; T-bet), which was a pivotal transcriptional regulation gene for Th1/Th2 polarization, and the development risk of esophagus squamous cell carcinoma (ESCC) was assessed in a high-risk Chinese population. A total of 302 ESCC cases and 311 normal controls coming from the highest incidence area of China were enrolled in this study. Three polymorphisms at −1499, −1514, and −1993 located in the TBX21 promoter were identified by the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. Logistic regression was used to determine whether the inherited variations of the TBX21 gene would associate with the risk and the clinicopathological characteristics of ESCC. Among the ESCC patients, an association between the TBX21 −1514T/C or −1993T/C polymorphisms and the lymph node or distant metastasis was found (odds ratios (ORs) were 9.46 and 4.35, respectively, all P < 0.01). By the log-additive model analysis, the results exhibited that three haplotypes, ACC, ACT, and ATC, were significantly related to the development risk of ESCC (OR = 11.81, 3.44, 2.37, respectively, all P < 0.05). TBX21 gene −1514 and −1993 polymorphisms might be counted as the influential factors for lymph node and distant metastasis to ESCC. Especially, the ACC, ACT, and ATC haplotypes derived from the TBX21 gene would increase the susceptibility to ESCC in the high-risk Chinese population.

Rasool S, Ganai BA, Syed Sameer A, Masood A. Esophageal cancer: associated factors with special reference to the Kashmir Valley. Tumori. 2012;98:191–203. PubMed: 22677984.PubMed

Pennathur A, Gibson MK, Jobe BA, Luketich JD. Oesophageal carcinoma. Lancet. 2013;381:400–12. PubMed: 23374478.CrossRefPubMed

Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics. CA Cancer J Clin. 2009;59:225–49. PubMed: 19474385.CrossRefPubMed

Kumagai Y, Kawada K, Yamazaki S, Iida M, Ochiai T, Momma K, et al. Endocytoscopic observation of esophageal squamous cell carcinoma. Dig Endosc. 2010;22:10–6. PubMed: 20078658.CrossRefPubMed

Shammas MA. Repetitive sequences, genomic instability and Barrett’s esophageal adenocarcinoma. Mob Genet Elem. 2011;1:208–12. PubMed: 22479688.CrossRef

Mao WM, Zheng WH, Ling ZQ. Epidemiologic risk factors for esophageal cancer development. Asian Pac J Cancer Prev. 2011;12:2461–6. PubMed: 22320939.PubMed

Uedo N, Jung HY, Fujishiro M, Lee IL, Zhou PH, Chiu PW, et al. Current situation of endoscopic submucosal dissection for superficial neoplasms in the upper digestive tract in East Asian countries: a questionnaire survey. Dig Endosc. 2012;24 Suppl 1:124–8. PubMed: 22533767.CrossRefPubMed

Roshandel G, Sadjadi A, Aarabi M, Keshtkar A, Sedaghat SM, Nouraie SM, et al. Cancer incidence in Golestan Province: report of an ongoing population-based cancer registry in Iran between 2004 and 2008. Arch Iran Med. 2012;15:196–200. PubMed: 22424034.PubMed

Lone GN, Sheikh AA, Sheikh ZA, Baba KM, Qurieshi MA, Mufti GN, et al. Role of preoperative chemotherapy in squamous cell carcinoma of esophagus in Kashmir, a cancer belt—a pilot study. Asian Pac J Cancer Prev. 2011;12:465–70. PubMed: 21545214.PubMed

10.

Cao B, Tian X, Li Y, Jiang P, Ning T, Xing H, et al. LMP7/TAP2 gene polymorphisms and HPV infection in esophageal carcinoma patients from a high incidence area in China. Carcinogenesis. 2005;26:1280–4. PubMed: 15774487.CrossRefPubMed

11.

Zandberg DP, Bhargava R, Badin S, Cullen KJ. The role of human papillomavirus in nongenital cancers. CA Cancer J Clin. 2013;63:57–81. PubMed: 23258613.CrossRefPubMed

12.

Alizadeh AM, Rohandel G, Roudbarmohammadi S, Roudbary M, Sohanaki H, Ghiasian SA, et al. Fumonisin B1 contamination of cereals and risk of esophageal cancer in a high risk area in northeastern Iran. Asian Pac J Cancer Prev. 2012;13:2625–8. PubMed: 22938431.CrossRefPubMed

13.

Conteduca V, Sansonno D, Ingravallo G, Marangi S, Russi S, Lauletta G, et al. Barrett’s esophagus and esophageal cancer: an overview. Int J Oncol. 2012;41:414–24. PubMed: 22615011.PubMed

14.

Joshi NS, Cui W, Dominguez CX, Chen JH, Hand TW, Kaech SM. Increased numbers of preexisting memory CD8 T cells and decreased T-bet expression can restrain terminal differentiation of secondary effector and memory CD8 T cells. J Immunol. 2011;187:4068–76. PubMed: 21930973.CrossRefPubMedPubMedCentral

15.

Bending D, Newland S, Krejci A, Phillips JM, Bray S, Cooke A. Epigenetic changes at Il12rb2 and Tbx21 in relation to plasticity behavior of Th17 cells. J Immunol. 2011;186:3373–82. PubMed: 21307296.CrossRefPubMed

16.

Qu Y, Chen L, Lowe DB, Storkus WJ, Taylor JL. Combined Tbet and IL12 gene therapy elicits and recruits superior antitumor immunity in vivo. Mol Ther. 2012;20:644–51. PubMed: 22215017.CrossRefPubMedPubMedCentral

17.

Reppert S, Boross I, Koslowski M, Türeci Ö, Koch S, Lehr HA, et al. A role for T-bet-mediated tumour immune surveillance in anti-IL-17A treatment of lung cancer. Nat Commun. 2011;2:600. PubMed: 22186896.CrossRefPubMed

18.

Ladoire S, Arnould L, Mignot G, Apetoh L, Rébé C, Martin F, et al. T-bet expression in intratumoral lymphoid structures after neoadjuvant trastuzumab plus docetaxel for HER2-overexpressing breast carcinoma predicts survival. Br J Cancer. 2011;105:366–71. PubMed: 21750556.CrossRefPubMedPubMedCentral

19.

Chen LJ, Zheng X, Shen YP, Zhu YB, Li Q, Chen J, et al. Higher numbers of T-bet(+) intratumoral lymphoid cells correlate with better survival in gastric cancer. Cancer Immunol Immunother. 2013;62:553–61. PubMed: 23090288.CrossRefPubMed

20.

Morita M, Watanabe M, Inoue N, Inaoka C, Akamizu T, Tatsumi KI, et al. Functional polymorphisms in TBX21 and HLX are associated with development and prognosis of Graves’ disease. Autoimmunity. 2012;45:129–36. PubMed: 22014209.CrossRefPubMed

21.

Cao B, Yang H, Ding H, Qi S, Gao L, Cui H, et al. Association analysis of hepatitis virus B infection with haplotypes of the TBX21 gene promoter region in the Chinese population. Clin Chem Lab Med. 2007;45:333–8. PubMed: 17378728.CrossRefPubMed

22.

Li J, You Y, Chen S. The role of upstream stimulatory factor 1 in the transcriptional regulation of the human TBX21 promoter mediated by the T-1514C polymorphism associated with systemic lupus erythematosus. Immunogenetics. 2012;64:361–70. PubMed: 22258560.CrossRefPubMed

23.

Akahoshi M, Obara K, Hirota T, Matsuda A, Hasegawa K, Takahashi N, et al. Functional promoter polymorphism in the TBX21 gene associated with aspirin-induced asthma. Hum Genet. 2005;17:16–26. PubMed: 15806396.CrossRef

24.

Rice TW, Blackstone EH, Rusch VW. 7th Edition of the AJCC cancer staging manual: esophagus and esophagogastric junction. Ann Surg Oncol. 2010;17:1721–4. PubMed: 20369299.CrossRefPubMed

25.

Cao B, Zhu L, Zhu S, Li D, Zhang C, Xu C, et al. Genetic variations and haplotypes in TIM-3 gene and the risk of gastric cancer. Cancer Immunol Immunother. 2010;59:1851–7. PubMed: 20811886.CrossRefPubMed

26.

Cao B, Dong S, Su Q, Yan B, Zhen H, Yuan Z, et al. Lack of association between the unique LMP2 gene polymorphism and the outcome of lung cancer in a population of Chinese Han nationality. Hum Immunol. 2012;73:580–4. PubMed: 22261389.CrossRefPubMed

27.

Li Z, Zhang Z, He Z, Tang W, Li T, Zeng Z, et al. A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis (http://analysis.bio-x.cn). Cell Res. 2009;19:519–23. PubMed: 19290020.CrossRefPubMed

28.

Enomoto K, Sho M, Wakatsuki K, Takayama T, Matsumoto S, Nakamura S, et al. Prognostic importance of tumour-infiltrating memory T cells in oesophageal squamous cell carcinoma. Clin Exp Immunol. 2012;168:186–91. PubMed: 22471279.CrossRefPubMedPubMedCentral

29.

Ichiki Y, Hanagiri T, Takenoyama M, Baba T, Nagata Y, Mizukami M, et al. Differences in sensitivity to tumor-specific CTLs between primary and metastatic esophageal cancer cell lines derived from the same patient. Surg Today. 2012;42:272–9. PubMed: 22234743.CrossRefPubMed

30.

Yeo CJ, Fearon DT. T-bet-mediated differentiation of the activated CD8+ T cell. Eur J Immunol. 2011;41:60–6. PubMed: 21182077.CrossRefPubMed

31.

Mohr E, Cunningham AF, Toellner KM, Bobat S, Coughlan RE, Bird RA, et al. IFN-{gamma} produced by CD8 T cells induces T-bet-dependent and -independent class switching in B cells in responses to alum-precipitated protein vaccine. Proc Natl Acad Sci U S A. 2010;107:17292–7. PubMed: 20855629.CrossRefPubMedPubMedCentral

32.

Lee K, Min HJ, Jang EJ, Hong JH, Hwang ES. In vivo tumor suppression activity by T cell-specific T-bet restoration. Int J Cancer. 2010;127:2129–37. PubMed: 20143391.CrossRefPubMed

33.

Li JR, Li JG, Deng GH, Zhao WL, Dan YJ, Wang YM, et al. A common promoter variant of TBX21 is associated with allele specific binding to Yin-Yang 1 and reduced gene expression. Scand J Immunol. 2011;73:449–58. PubMed: 21272048.CrossRefPubMed

34.

Oestreich KJ, Huang AC, Weinmann AS. The lineage-defining factors T-bet and Bcl-6 collaborate to regulate Th1 gene expression patterns. J Exp Med. 2011;208:1001–13. PubMed: 21518797.CrossRefPubMedPubMedCentral

35.

Garrett WS, Punit S, Gallini CA, Michaud M, Zhang D, Sigrist KS, et al. Colitis-associated colorectal cancer driven by T-bet deficiency in dendritic cells. Cancer Cell. 2009;16:208–19. PubMed: 19732721.CrossRefPubMedPubMedCentral

36.

Lin TC, Chen SU, Chen YF, Chang YC, Lin CW. Intramucosal variant of nasal natural killer (NK)/T cell lymphoma has a better survival than does invasive variant: implication on loss of E26 transformation-specific sequence 1 (ETS-1) and T-box expressed in T cells (T-bet) with invasion. Histopathology. 2012;60:287–95. PubMed: 22211287.CrossRefPubMed

Title: Association between the genetic variations within TBX21 gene promoter and the clinicopathological characteristics of esophageal squamous cell carcinoma in a high-risk Chinese population
Authors: Huihui Li
Hongchao Zhen
Lei Han
Bo Yan
Jing Yu
Shengtao Zhu
Bangwei Cao
Publication date: 01-05-2015
Publisher: Springer Netherlands
Published in: Tumor Biology / Issue 5/2015
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI: https://doi.org/10.1007/s13277-015-3042-x

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2015

Protein interactions of cortactin in relation to invadopodia formation in metastatic renal clear cell carcinoma

Overexpression of ETV4 is associated with poor prognosis in prostate cancer: involvement of uPA/uPAR and MMPs

Antitumor effect of free rhodium (II) citrate and rhodium (II) citrate-loaded maghemite nanoparticles on mice bearing breast cancer: a systemic toxicity assay

Increased expression of miR-93 is associated with poor prognosis in head and neck squamous cell carcinoma

XRCC1 genetic polymorphism acts a potential biomarker for lung cancer

Demethylation-mediated miR-129-5p up-regulation inhibits malignant phenotype of osteogenic osteosarcoma by targeting Homo sapiens valosin-containing protein (VCP)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer